Modulating Mitochondrial Pyruvate Carrier: A Promising Therapeutic Target in Parkinson's Disease

被引：1
|
作者：
Orgaz, Lorena [1 ]
Bueno Gil, Guillermo [1 ]
机构：
[1] CSIC, Cajal Inst, Madrid, Spain
来源：
MOVEMENT DISORDERS | 2017年 / 32卷 / 05期
关键词：
D O I：
10.1002/mds.26962
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：719 / 719
页数：1
相关论文
共 50 条
  • [1] Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease
    Yao, Meng-Fan
    Dang, Tao
    Wang, Hua-Jun
    Zhu, Xiao-Zhong
    Qiao, Chen
    BEHAVIOURAL BRAIN RESEARCH, 2024, 459
  • [2] Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease?
    Burtscher, Johannes
    Syed, Muhammed Muazzam Kamil
    Lashuel, Hilal A.
    Millet, Gregoire P.
    MOVEMENT DISORDERS, 2021, 36 (04) : 857 - 861
  • [3] The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease
    McCommis, Kyle S.
    Finck, Brian N.
    BIOMOLECULES, 2023, 13 (02)
  • [4] Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease
    Md Zeeshan Rasheed
    Heena Tabassum
    Suhel Parvez
    Protoplasma, 2017, 254 : 33 - 42
  • [5] Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease
    Rasheed, Md Zeeshan
    Tabassum, Heena
    Parvez, Suhel
    PROTOPLASMA, 2017, 254 (01) : 33 - 42
  • [6] Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson?s Disease
    Tryphena, Kamatham Pushpa
    Nikhil, Uppala Sai
    Pinjala, Poojitha
    Srivastava, Saurabh
    Singh, Shashi Bala
    Khatri, Dharmendra Kumar
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (08): : 1356 - 1368
  • [7] Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease
    Labandeira-Garcia, Jose L.
    Rodriguez-Perez, Ana I.
    Villar-Cheda, Begona
    Borrajo, Ana
    Dominguez-Meijide, Antonio
    Guerra, Maria J.
    NEUROSCIENTIST, 2015, 21 (06): : 616 - 629
  • [8] Th17 cells: a promising therapeutic target for Parkinson's disease?
    Prots, Iryna
    Winner, Beate
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (04) : 309 - 314
  • [9] Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease
    Ghosh, Anamitra
    Tyson, Trevor
    George, Sonia
    Hildebrandt, Erin N.
    Steiner, Jennifer A.
    Madaj, Zachary
    Schulz, Emily
    Machiela, Emily
    McDonald, William G.
    Galvis, Martha L. Escobar
    Kordower, Jeffrey H.
    Van Raamsdonk, Jeremy M.
    Colca, Jerry R.
    Brundin, Patrik
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (368)
  • [10] Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for Parkinson's disease
    Xiao, Zhixin
    Wang, Xiaoya
    Pan, Xuening
    Xie, Junxia
    Xu, Huamin
    EXPERIMENTAL NEUROLOGY, 2024, 372
12345